Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful treatment of young childhood standard-risk hepatoblastoma with cisplatin monotherapy using a central review system.
Saeki I, Ida K, Kurihara S, Watanabe K, Mori M, Hishiki T, Yokoi A, Fujimura J, Honda S, Nogami Y, Iehara T, Kazama T, Sekiguchi M, Kitagawa N, Matsumura R, Nomura M, Yamada Y, Hanaki R, Kaneda H, Takama Y, Inoue T, Tanaka Y, Miyazaki O, Nagase H, Takimoto T, Yoshimura K, Hiyama E. Saeki I, et al. Among authors: kaneda h. Pediatr Blood Cancer. 2024 Nov;71(11):e31255. doi: 10.1002/pbc.31255. Epub 2024 Aug 10. Pediatr Blood Cancer. 2024. PMID: 39126361
Establishing a new human lung squamous cell carcinoma cell line, OMUL-1, expressing insulin-like growth factor 1 receptor and programmed cell death ligand 1.
Nagamine H, Yashiro M, Mizutani M, Sugimoto A, Matsumoto Y, Tani Y, Kaneda H, Yamada K, Watanabe T, Asai K, Suzuki S, Kawaguchi T. Nagamine H, et al. Among authors: kaneda h. Thorac Cancer. 2025 Jan;16(1):e15488. doi: 10.1111/1759-7714.15488. Epub 2024 Nov 17. Thorac Cancer. 2025. PMID: 39552203 Free PMC article.
Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer.
Nagamine H, Yashiro M, Mizutani M, Sugimoto A, Matsumoto Y, Tani Y, Sawa K, Kaneda H, Yamada K, Watanabe T, Asai K, Suzuki S, Kawaguchi T. Nagamine H, et al. Among authors: kaneda h. PLoS One. 2024 Oct 4;19(10):e0297397. doi: 10.1371/journal.pone.0297397. eCollection 2024. PLoS One. 2024. PMID: 39365756 Free PMC article.
Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer.
Sugimoto A, Kaneda H, Yoshimoto N, Nagata K, Fujii T, Michimoto K, Ueno S, Kamimori T, Ishii Y, Sakagami M, Inokuchi H, Shibuya K, Mizutani M, Nagamine H, Nakahama K, Matsumoto Y, Tani Y, Sawa K, Kawaguchi T. Sugimoto A, et al. Among authors: kaneda h. Sci Rep. 2024 Aug 23;14(1):19596. doi: 10.1038/s41598-024-70214-y. Sci Rep. 2024. PMID: 39179598 Free PMC article.
613 results